PRX-03140

DB05596InvestigationalSmall molecule

Investigated for use/treatment in alzheimer's disease and memory loss.

Mechanism: Pharmacologically active on 5-hydroxytryptamine receptor 4
Curator reviewed
Primary indication: Investigated for use/treatment in alzheimer's disease and memory loss.Curator reviewed
Formula / weight: C₁₉H₂₇N₃O₃S · 377.5 g/mol (avg)
Code names: PRX-03140

Resolves to

Compound

Structure

InChIKeySCHKZZSVELPJKU-UHFFFAOYSA-NSMILESCC(C)N1C2=C(C=CS2)C(O)=C(C(=O)NCCCN2CCCCC2)C1=O

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

3Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with PRX-03140, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.